ANX-188

· Mast Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANX-188, covering 2015-05-20 to 2015-05-20. Get the full timeline:

Most recent: Clinical Trial Update: ANX-188 Thorough QT/QTc Study in Healthy Volunteers [Phase 1]